Sirolimus (albumin-bound) for injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sirolimus (albumin-bound) for injection, covering 2025-04-16 to 2025-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors [Phase 3]